Uveitis as a marker of active arthritis in 372 patients with juvenile idiopathic seronegative oligoarthritis or

K Kotaniemi1, A Kotaniemi, A Savolainen

  • 1Department of Ophthalmology, Helsinki University Hospital, Finland.

Insights

Children with juvenile idiopathic arthritis (JIA) and uveitis show increased inflammatory arthritis activity. This indicates a need for closer monitoring and tailored treatment strategies for JIA patients with uveitis.

Area of Science:

  • Pediatric Rheumatology
  • Ophthalmology
  • Immunology

Background:

  • Juvenile idiopathic arthritis (JIA) is a common rheumatic disease in children.
  • Uveitis, an inflammatory eye condition, can be associated with JIA.
  • Seronegative oligoarthritis and polyarthritis are subtypes of JIA.

Purpose of the Study:

  • To compare arthritis activity in children with recently diagnosed seronegative oligoarthritis or polyarthritis, with and without uveitis.
  • To evaluate the impact of uveitis on disease activity and treatment in JIA.

Main Methods:

  • A prospective study of 372 children with recently diagnosed seronegative oligoarthritis or polyarthritis.
  • Assessment of arthritis activity using clinical and laboratory parameters over a mean follow-up of 4.5 years.
  • Comparison of disease characteristics between JIA patients with and without asymptomatic anterior uveitis.

Main Results:

  • Patients with uveitis had higher erythrocyte sedimentation rates and lower hemoglobin levels at diagnosis.
  • Increased joint inflammation and greater need for systemic corticosteroids and methotrexate were observed in patients with uveitis.
  • Clinical remission rates were significantly lower in JIA patients with uveitis (21%) compared to those without (42%).

Conclusions:

  • The inflammatory activity of arthritis is heightened in children with seronegative oligoarthritis or polyarthritis and uveitis.
  • Uveitis is associated with more severe arthritis and poorer treatment outcomes in JIA.
  • These findings underscore the importance of screening for uveitis in JIA and managing co-existing conditions aggressively.
Abstract